26 Apr Innovation Digest – April 2022 Vol. 2
Why does it take us ten years to learn how to reduce low-value care or to implement an evidence-based practice? Why is a pandemic necessary to understand the value of a safety net health program like Medicaid and to realize the consequence of taking such a safety net away from people who may be healthier because they had access? Complacency about the time and data required to prove value is a major obstacle to change. I’ve been watching the resurgence of interest in real-world data with both skepticism and enthusiasm: is it a hot topic because leveraging information about real patient experience can inform actual patient-centered care, or is it another opportunity to monetize our information in ways that feed the health-industrial complex? For the last three decades (and especially since I joined IVI in 2018), I’ve embraced Dr. Jain’s “radical common sense” idea that health care (innovation/design/delivery/payment/quality measurement) should always do what is right for the patient. We absolutely have the ability and resources to understand how patients can be represented in population data AND as individuals who may differ in their needs and experience of a health condition based on physical, financial, and geographical factors. My metric for evaluating studies that use RWD or that talk about value-based anything: were patients (and families and caregivers) co-leading (or leading!) the study design, defining data of importance, and evaluating its use for decision-making? I don’t think that’s radical, but it’s definitely common sense if we really want to pay for value in health.
In this issue:
- Everybody’s Talking About Value-Based Health Care. Here’s What They’re Not Saying.
- What have we learned after ten years of “Choosing Wisely”?
- Why Pharma Should Commit To Population Health
- End of Medicaid continuous coverage may leave millions of children uninsured, analysis finds
- Some physicians are uneasy as Colorado collects providers’ diversity data